NEONATAL CARDIAC FAILURE

NEONATAL CARDIAC FAILURE was reported 90 times

NEONATAL CARDIAC FAILURE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Surfactant [EPC] 1 0.0009
1 alpha-1 Adrenergic Agonist [EPC] 2 0.0005
2 Thyroid Hormone Synthesis Inhibitor [EPC] 2 0.0002
3 Anticholinergic [EPC] 3 0.0002
4 Vitamin K [EPC] 1 0.0001
5 Lipid-based Polyene Antifungal [EPC] 1 0.0001
6 Catecholamine [EPC] 5 0.0001
7 Progesterone [EPC] 1 0.0000
8 Provitamin D2 Compound [EPC] 1 0.0000
9 Glycopeptide Antibacterial [EPC] 2 0.0000
10 Nonsteroidal Anti-inflammatory Drug [EPC] 36 0.0000
11 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
12 Polyene Antifungal [EPC] 1 0.0000
13 General Anesthetic [EPC] 1 0.0000
14 Protease Inhibitor [EPC] 1 0.0000
15 Aminoglycoside Antibacterial [EPC] 1 0.0000
16 Serotonin-3 Receptor Antagonist [EPC] 3 0.0000
17 Aminosalicylate [EPC] 2 0.0000
18 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
19 Cholinergic Nicotinic Agonist [EPC] 1 0.0000
20 Cardiac Glycoside [EPC] 1 0.0000
21 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
22 Integrin Receptor Antagonist [EPC] 1 0.0000
23 Nitrate Vasodilator [EPC] 1 0.0000
24 Prostaglandin Analog [EPC] 1 0.0000
25 Purine Antimetabolite [EPC] 1 0.0000
26 Mood Stabilizer [EPC] 2 0.0000
27 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
28 Anti-epileptic Agent [EPC] 2 0.0000
29 Alkylating Drug [EPC] 2 0.0000
30 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
31 Leukocyte Growth Factor [EPC] 1 0.0000
32 Aldosterone Antagonist [EPC] 1 0.0000
33 Azole Antifungal [EPC] 1 0.0000
34 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
35 Interferon beta [EPC] 1 0.0000
36 Corticosteroid [EPC] 6 0.0000
37 Loop Diuretic [EPC] 2 0.0000
38 Platinum-based Drug [EPC] 1 0.0000
39 beta-Adrenergic Blocker [EPC] 1 0.0000
40 Insulin Analog [EPC] 1 0.0000
41 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
42 Kinase Inhibitor [EPC] 1 0.0000
43 Proton Pump Inhibitor [EPC] 1 0.0000